| 发明名称 |
FORMULAÇÃO LIOFILIZADA ESTÁVEL PREPARADA, FORMULAÇÃO RECONSTITUÍDA ESTÁVEL, MÉTODO PARA PREPARAR FORMULAÇÃO RECONSTITUÍDA ESTÁVEL E PARA TRATAR INDIVÍDUO |
| 摘要 |
The present invention relates generally to the field of pharmaceutical formulation of immunoglobulins. Specifically, the present invention relates to stable, lyophilized, high concentration immunoglobulin formulations. This invention is exemplified by a stabilized lyophilized formulation of the recombinant humanized anti-alpha-4 integrin antibody natalizumab. |
| 申请公布号 |
BRPI0812561(A2) |
申请公布日期 |
2014.10.29 |
| 申请号 |
BR2008PI12561 |
申请日期 |
2008.06.13 |
| 申请人 |
ELAN PHARMACEUTICALS, INC. |
发明人 |
BARBARA HORSEY O'CONNOR;SHAUN E. BUCKLEY;DAVID J. BURKE;SHERWOOD RUSS LEHRMAN |
| 分类号 |
A61K39/395;G01N33/574 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
